New paper from our group!


In collaboration with Alan Kozikowski group (Starwise Therapeutics) we designed, synthesized and evaluated a series of PSMA inhibitors derived from 2-aminoadipic acid, a building block that has not previously been used to construct PSMA ligands (published in ACS Med Chem Lett). These ligands with picomolar affinity for PSMA can serve as a scaffold for the development of theranostics targeting prostate carcinoma. Congratulation to Zorka and Lucka for excellent job!